what was the first glp-1 agonist Understanding receptor agonists and their impact on drug discovery Figure 2, Health Canada Approval
Description
The real problem seems to be retention

A 2026 analysis of 25 products found zero contained semaglutide

The global obesity treatment market is expanding at unprecedented speed, with sales of weight-loss medications forecast to rise dramatically over the next decade.

It does not titrate up

Clinically backed oral GLP-1 support with a 321% natural GLP-1 boost
